Bruce Weaver

Bruce Beutel is a seasoned executive in the biotechnology and pharmaceutical sectors with extensive experience in both leadership and advisory roles. Currently serving as Co-Founder and Chief Executive Officer at Passkey Therapeutics, Bruce also holds board positions at Enveda Biosciences, Boston Immune Technologies & Therapeutics, GRO Biosciences, and Stellular Bio. Previously, Bruce was Chief Strategy and Business Officer at Dewpoint Therapeutics and held significant roles at SQZ Biotechnologies and Merck, where responsibilities included business development, strategic partnerships, and leading research teams. Bruce's academic background includes a Ph.D. in Molecular Biology from the University of Wisconsin-Madison and a Bachelor's Degree in Biology with Honors from the University of Chicago.